Close

Janssen Research (JNJ) Reports Breakthrough Therapy Designation for Esketamine

August 16, 2016 9:04 AM EDT Send to a Friend
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login